[1]
S. TK and K. Madhyastha, “A prospective randomized double blinded study to evaluate the efficacy of dexmedetomidine 50 μg intravenously and perineurally as an adjunct to 0.5% ropivacaine for supraclavicular brachial plexus block”, apic, vol. 21, no. 4, pp. 413-419, Jan. 2019.